Not at all, it’s still part of our patents and TAVR offering. It’s just that the focus at the moment is on the DurAVR single piece valve in a SAVR setting which has to be proven first as it’s the most critical component.
The other stuff is good and nice to have but it really is 90% about the valve and maybe 10% or less for the delivery system. Our main competitive advantage is in the valve science and design - DurAVR.
DYOR and Not advice.
Not at all, it’s still part of our patents and TAVR offering....
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |